How do I buy Tarsus Pharmaceuticals (TARS) stock?

You can purchase shares of Tarsus Pharmaceuticals (NASDAQ:TARS) through any online brokerage.View our list of the best stock brokerages

Who are Tarsus Pharmaceuticals (TARS) competitors?

Other companies in Tarsus Pharmaceuticals’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Terns Pharmaceuticals Inc (NASDAQ:TERN), Axsome Therapeutics Inc (NASDAQ:AXSM) and Alumis Inc (NASDAQ:ALMS).

What is the forecast, or price target, for Tarsus Pharmaceuticals (TARS) stock?

Tarsus Pharmaceuticals has a consensus price target of $73.30.

What is the current price for Tarsus Pharmaceuticals (TARS)?

The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $70.39 last updated January 20, 2026 at 4:04 PM EST.

Does Tarsus Pharmaceuticals (TARS) pay a dividend?

There are no upcoming dividends for Tarsus Pharmaceuticals.

When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?

Tarsus Pharmaceuticals does not have any upcoming earnings scheduled.

Is Tarsus Pharmaceuticals (TARS) going to split?

There is no upcoming split for Tarsus Pharmaceuticals.

What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?

Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Tarsus Pharmaceuticals (TARS) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

Comments